SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pbio.3001531
PubMed Identifier: 35143473
Publication URI: http://europepmc.org/abstract/MED/35143473
Type: Journal Article/Review
Volume: 20
Parent Publication: PLoS biology
Issue: 2
ISSN: 1544-9173